tykhr
sign in
free sign up
Amylyx Pharmaceuticals Inc
Biotechnology
Healthcare
AMLX
68.09 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
6.41
52 week high
7.03
high
6.50
52 week low
2.88
low
6.03
growth
138.93 %
previous Close
6.41
P/E ratio
-6
market cap
278 M
div yield
0
usd
Sep 2024
qoq
revenue
416 K
140.66 %
net incoming
-72.70 M
-0.01 %
eps
-1.07 %
-46.58 %
eps surprise
-16.94 %
net profit margin
-17476.92 %
-24583.00 %
operating incoming
-75.66 M
-41.59 %
net change in cash
-1.72 M
98.20 %
cash on hand
71.84 M
-4.21 %
cost of revenue
809 K
-89.39 %
top